AUTOLUS THERAPEUTICS PLC filings

SEC filings by AUTOLUS THERAPEUTICS PLC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-03-25Kellnerova RenataAutolus Therapeutics plc14,612,2755.5%EDGAR
SC 13D2024-02-21BioNTech SEAutolus Therapeutics plc33,333,33312.5%EDGAR
SC 13G/A2024-02-14Paradigm Biocapital Advisors LPAutolus Therapeutics plc12,611,3357.2%EDGAR
SC 13G/A2024-02-14Deep Track Capital, LPAutolus Therapeutics plc11,869,2976.8%EDGAR
SC 13G/A2024-02-14ARMISTICE CAPITAL, LLCAutolus Therapeutics plc3,850,0002.2%EDGAR
SC 13G/A2024-02-13Syncona Portfolio LtdAutolus Therapeutics plc33,527,16214.4%EDGAR
SC 13G/A2024-01-31Tetragon Financial Management LPAutolus Therapeutics plc8,000,0004.6%EDGAR
SC 13G2023-07-10Paradigm Biocapital Advisors LPAutolus Therapeutics plc10,098,5845.8%EDGAR
SC 13G2023-03-20Tetragon Financial Management LPAutolus Therapeutics plc9,461,8835.5%EDGAR
SC 13G/A2023-02-14Nantahala Capital Management, LLCAutolus Therapeutics plc7,782,0184.7%EDGAR
SC 13G/A2023-02-14Deep Track Capital, LPAutolus Therapeutics plc15,000,0008.7%EDGAR
SC 13G/A2023-02-14Syncona Portfolio LtdAutolus Therapeutics plc33,527,16219.7%EDGAR
SC 13G/A2023-02-14Frazier Life Sciences Public Fund, L.P.Autolus Therapeutics plc3,025,9061.7%EDGAR
SC 13G2023-02-14ARMISTICE CAPITAL, LLCAutolus Therapeutics plc10,224,0005.9%EDGAR
SC 13G/A2023-02-13Capital World InvestorsAutolus Therapeutics plc625,0000.4%EDGAR
SC 13G2022-12-19Deep Track Capital, LPAutolus Therapeutics plc15,000,0009.0%EDGAR
SC 13D/A2022-12-13Blackstone Inc.Autolus Therapeutics plc23,750,91714.0%EDGAR
SC 13G2022-12-13Qatar Investment AuthorityAutolus Therapeutics plc15,000,0009.0%EDGAR
SC 13D/A2022-10-05PPF Biotech B.V.Autolus Therapeutics plc14,612,27516.1%EDGAR
SC 13G2022-02-14Nantahala Capital Management, LLCAutolus Therapeutics plc4,077,5095.6%EDGAR